spacer
spacer
Go to PDB code: 
protein ligands Protein-protein interface(s) links
Complex (antigen/peptide) PDB id
1a1o
Jmol
Contents
Protein chains
276 a.a. *
99 a.a. *
Ligands
LYS-PRO-ILE-VAL-
GLN-TYR-ASP-ASN-
PHE
Waters ×113
* Residue conservation analysis
PDB id:
1a1o
Name: Complex (antigen/peptide)
Title: Mhc class i molecule b 5301 Complexed with peptide ls6 (kpivqydnf) from the malaria parasite p. Falciparum
Structure: Hla class i histocompatibility antigen, bw-53 b 5301 Alpha chain. Chain: a. Synonym: b53. Engineered: yes. Beta-2-microglobulin. Chain: b. Synonym: b53. Engineered: yes.
Source: Homo sapiens. Human. Organism_taxid: 9606. Cell_line: bl21. Gene: t7. Expressed in: escherichia coli. Expression_system_taxid: 562. Human immunodeficiency virus 1. Organism_taxid: 11676
Biol. unit: Dimer (from PDB file)
Resolution:
2.30Å     R-factor:   0.168    
Authors: K.J.Smith,S.W.Reid,K.Harlos,A.J.Mcmichael,D.I.Stuart, J.I.Bell,E.Y.Jones
Key ref:
K.J.Smith et al. (1996). Bound water structure and polymorphic amino acids act together to allow the binding of different peptides to MHC class I HLA-B53. Immunity, 4, 215-228. PubMed id: 8624812 DOI: 10.1016/S1074-7613(00)80430-6
Date:
11-Dec-97     Release date:   08-Apr-98    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P30491  (1B53_HUMAN) -  HLA class I histocompatibility antigen, B-53 alpha chain
Seq:
Struc:
362 a.a.
276 a.a.*
Protein chain
Pfam   ArchSchema ?
P61769  (B2MG_HUMAN) -  Beta-2-microglobulin
Seq:
Struc:
119 a.a.
99 a.a.
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 1 residue position (black cross)

 Gene Ontology (GO) functional annotation 
  GO annot!
  Cellular component     extracellular region   8 terms 
  Biological process     immune response   8 terms 
  Biochemical function     protein binding     1 term  

 

 
DOI no: 10.1016/S1074-7613(00)80430-6 Immunity 4:215-228 (1996)
PubMed id: 8624812  
 
 
Bound water structure and polymorphic amino acids act together to allow the binding of different peptides to MHC class I HLA-B53.
K.J.Smith, S.W.Reid, K.Harlos, A.J.McMichael, D.I.Stuart, J.I.Bell, E.Y.Jones.
 
  ABSTRACT  
 
The structure of the human MHC class I molecule HLA-B53 complexed to two nonameric peptide epitopes (from the malaria parasite P. falciparum and the HIV2 gag protein) has been determined by X-ray crystallography at 2.3 angstrom resolution. The structures reveal the architecture of a Pro-specific B pocket common to many HLA-B alleles. Relative to other alleles, the B53 peptide-binding groove is widened by a significant (up to 1.25 angstrom) shift in the position of the alpha 1 helix. Within this groove, bound water molecules, acting in concert with the side chains of polymorphic residues, provide the functional malleability of the MHC, which enables the high affinity/low specificity binding of multiple peptide epitopes.
 
  Selected figure(s)  
 
Figure 3.
Figure 3. The B53 Peptide-Binding Groove(A) The surface of the MHC-binding groove in the ls6 complex is colored according to electrostatic potential (calculated in the absence of the peptide or bound water molecules); blue denotes positive potential and red indicates negative potential. Electrostatic analysis and surface display used program GRASP ([31]); the view of the peptide is similar to that of Figure 1.(B) The electrostatic potential surface of B53 in the HIV2 complex.
Figure 5.
Figure 5. The Peptide-Binding Surface of B53Peptide residues are colored red. The B53 main chain is represented schematically in blue and key side chains are shown in white; dashed lines indicate hydrogen bonds and, in (B) and (C), green spheres mark the positions of tightly bound water molecules.(A) Stereodiagram of the B pocket. The view is through the α1 helix.(B) The central region in the ls6 complex. The view for this and the following panels is through the α2 helix.(C) The central region in the HIV2 complex.(D) The F pocket, showing favorable ring stacking between the ls6 C-terminal (P9) peptide residue Phe and MHC residue Tyr123.
 
  The above figures are reprinted by permission from Cell Press: Immunity (1996, 4, 215-228) copyright 1996.  
  Figures were selected by the author.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
  18941220 B.Sanjanwala, M.Draghi, P.J.Norman, L.A.Guethlein, and P.Parham (2008).
Polymorphic sites away from the Bw4 epitope that affect interaction of Bw4+ HLA-B with KIR3DL1.
  J Immunol, 181, 6293-6300.  
18378495 J.K.Archbold, W.A.Macdonald, S.R.Burrows, J.Rossjohn, and J.McCluskey (2008).
T-cell allorecognition: a case of mistaken identity or déjà vu?
  Trends Immunol, 29, 220-226.  
18721770 R.Duquesnoy, S.Spellman, M.Haagenson, T.Wang, M.M.Horowitz, and M.Oudshoorn (2008).
HLAMatchmaker-defined triplet matching is not associated with better survival rates of patients with class I HLA allele mismatched hematopoietic cell transplants from unrelated donors.
  Biol Blood Marrow Transplant, 14, 1064-1071.  
17471455 H.H.Bui, A.J.Schiewe, and I.S.Haworth (2007).
WATGEN: an algorithm for modeling water networks at protein-protein interfaces.
  J Comput Chem, 28, 2241-2251.  
16597462 M.A.Joseph, M.L.Mitchell, J.D.Evanseck, J.R.Kovacs, L.Jia, H.Shen, and W.S.Meng (2007).
Secondary anchor substitutions in an HLA-A*0201-restricted T-cell epitope derived from Her-2/neu.
  Mol Immunol, 44, 322-331.  
18083574 M.Koch, S.Camp, T.Collen, D.Avila, J.Salomonsen, H.J.Wallny, A.van Hateren, L.Hunt, J.P.Jacob, F.Johnston, D.A.Marston, I.Shaw, P.R.Dunbar, V.Cerundolo, E.Y.Jones, and J.Kaufman (2007).
Structures of an MHC class I molecule from B21 chickens illustrate promiscuous peptide binding.
  Immunity, 27, 885-899.
PDB codes: 3bev 3bew
16470819 A.J.Bordner, and R.Abagyan (2006).
Ab initio prediction of peptide-MHC binding geometry for diverse class I MHC allotypes.
  Proteins, 63, 512-526.  
16323248 D.K.Cole, P.J.Rizkallah, F.Gao, N.I.Watson, J.M.Boulter, J.I.Bell, M.Sami, G.F.Gao, and B.K.Jakobsen (2006).
Crystal structure of HLA-A*2402 complexed with a telomerase peptide.
  Eur J Immunol, 36, 170-179.
PDB code: 2bck
16447245 H.H.Bui, A.J.Schiewe, H.von Grafenstein, and I.S.Haworth (2006).
Structural prediction of peptides binding to MHC class I molecules.
  Proteins, 63, 43-52.  
16533401 I.A.Doytchinova, P.Guan, and D.R.Flower (2006).
EpiJen: a server for multistep T cell epitope prediction.
  BMC Bioinformatics, 7, 131.  
16815841 L.L.Jones, S.E.Brophy, A.J.Bankovich, L.A.Colf, N.A.Hanick, K.C.Garcia, and D.M.Kranz (2006).
Engineering and characterization of a stabilized alpha1/alpha2 module of the class I major histocompatibility complex product Ld.
  J Biol Chem, 281, 25734-25744.  
  16511111 F.Chu, Z.Lou, B.Gao, J.I.Bell, Z.Rao, and G.F.Gao (2005).
Complex assembly, crystallization and preliminary X-ray crystallographic studies of rhesus macaque MHC Mamu-A*01 complexed with an immunodominant SIV-Gag nonapeptide.
  Acta Crystallogr Sect F Struct Biol Cryst Commun, 61, 614-616.  
15526297 J.Desmet, G.Meersseman, N.Boutonnet, J.Pletinckx, K.De Clercq, M.Debulpaep, T.Braeckman, and I.Lasters (2005).
Anchor profiles of HLA-specific peptides: analysis by a novel affinity scoring method and experimental validation.
  Proteins, 58, 53-69.  
15871042 R.Sainudiin, W.S.Wong, K.Yogeeswaran, J.B.Nasrallah, Z.Yang, and R.Nielsen (2005).
Detecting site-specific physicochemical selective pressures: applications to the Class I HLA of the human major histocompatibility complex and the SRK of the plant sporophytic self-incompatibility system.
  J Mol Evol, 60, 315-326.  
15213391 C.Kellenberger, S.Porciero, and A.Roussel (2004).
Expression, refolding, crystallization and preliminary crystallographic study of MHC H-2Kk complexed with octapeptides and nonapeptides.
  Acta Crystallogr D Biol Crystallogr, 60, 1278-1280.  
15167284 R.Winchester, J.Pitt, M.Charurat, L.S.Magder, H.H.Göring, A.Landay, J.S.Read, W.Shearer, E.Handelsman, K.Luzuriaga, G.V.Hillyer, and W.Blattner (2004).
Mother-to-child transmission of HIV-1: strong association with certain maternal HLA-B alleles independent of viral load implicates innate immune mechanisms.
  J Acquir Immune Defic Syndr, 36, 659-670.  
12939341 W.A.Macdonald, A.W.Purcell, N.A.Mifsud, L.K.Ely, D.S.Williams, L.Chang, J.J.Gorman, C.S.Clements, L.Kjer-Nielsen, D.M.Koelle, S.R.Burrows, B.D.Tait, R.Holdsworth, A.G.Brooks, G.O.Lovrecz, L.Lu, J.Rossjohn, and J.McCluskey (2003).
A naturally selected dimorphism within the HLA-B44 supertype alters class I structure, peptide repertoire, and T cell recognition.
  J Exp Med, 198, 679-691.
PDB codes: 1m6o 1n2r
12366790 H.A.Elsner, A.Himmel, M.Steitz, P.Hammer, G.Schmitz, M.Ballas, and R.Blasczyk (2002).
HLA-B*3531, a hybrid of B35 and B61, implications for diagnostic approaches to alleles with complex ancestral compositions.
  Tissue Antigens, 60, 95-97.  
11875071 L.Sesma, V.Montserrat, J.R.Lamas, A.Marina, J.Vázquez, and J.A.López de Castro (2002).
The peptide repertoires of HLA-B27 subtypes differentially associated to spondyloarthropathy (B*2704 and B*2706) differ by specific changes at three anchor positions.
  J Biol Chem, 277, 16744-16749.  
12010576 P.E.Adrian, G.Rajaseger, V.S.Mathura, M.K.Sakharkar, and P.Kangueane (2002).
Types of inter-atomic interactions at the MHC-peptide interface: identifying commonality from accumulated data.
  BMC Struct Biol, 2, 2.  
11312369 F.Buseyne, M.L.Chaix, C.Rouzioux, S.Blanche, and Y.Rivière (2001).
Patient-specific cytotoxic T-lymphocyte cross-recognition of naturally occurring variants of a human immunodeficiency virus type 1 (HIV-1) p24gag epitope by HIV-1-infected children.
  J Virol, 75, 4941-4946.  
11385619 L.Dorrell, B.E.Willcox, E.Y.Jones, G.Gillespie, H.Njai, S.Sabally, A.Jaye, K.DeGleria, T.Rostron, E.Lepin, A.McMichael, H.Whittle, and S.Rowland-Jones (2001).
Cytotoxic T lymphocytes recognize structurally diverse, clade-specific and cross-reactive peptides in human immunodeficiency virus type-1 gag through HLA-B53.
  Eur J Immunol, 31, 1747-1756.  
11172028 M.M.Addo, M.Altfeld, E.S.Rosenberg, R.L.Eldridge, M.N.Philips, K.Habeeb, A.Khatri, C.Brander, G.K.Robbins, G.P.Mazzara, P.J.Goulder, and B.D.Walker (2001).
The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individuals.
  Proc Natl Acad Sci U S A, 98, 1781-1786.  
11472639 P.Cano, and B.Fan (2001).
A geometric and algebraic view of MHC-peptide complexes and their binding properties.
  BMC Struct Biol, 1, 2.  
11053110 A.Simon, Z.Dosztányi, E.Rajnavölgyi, and I.Simon (2000).
Function-related regulation of the stability of MHC proteins.
  Biophys J, 79, 2305-2313.  
10634787 C.Wingren, M.P.Crowley, M.Degano, Y.Chien, and I.A.Wilson (2000).
Crystal structure of a gammadelta T cell receptor ligand T22: a truncated MHC-like fold.
  Science, 287, 310-314.
PDB code: 1c16
11098938 H.A.Elsner, and R.Blasczyk (2000).
Increased diversity within the HLA-B*07 group: identification of the two novel alleles B*0709 and B*0710.
  Tissue Antigens, 56, 371-375.  
  11045629 O.Schueler-Furman, Y.Altuvia, A.Sette, and H.Margalit (2000).
Structure-based prediction of binding peptides to MHC class I molecules: application to a broad range of MHC alleles.
  Protein Sci, 9, 1838-1846.  
10023771 A.Glithero, J.Tormo, J.S.Haurum, G.Arsequell, G.Valencia, J.Edwards, S.Springer, A.Townsend, Y.L.Pao, M.Wormald, R.A.Dwek, E.Y.Jones, and T.Elliott (1999).
Crystal structures of two H-2Db/glycopeptide complexes suggest a molecular basis for CTL cross-reactivity.
  Immunity, 10, 63-74.
PDB codes: 1ce6 1qlf
10023770 J.A.Speir, U.M.Abdel-Motal, M.Jondal, and I.A.Wilson (1999).
Crystal structure of an MHC class I presented glycopeptide that generates carbohydrate-specific CTL.
  Immunity, 10, 51-61.
PDB code: 1kbg
10631933 J.C.Solheim (1999).
Class I MHC molecules: assembly and antigen presentation.
  Immunol Rev, 172, 11-19.  
10429675 Q.R.Fan, and D.C.Wiley (1999).
Structure of human histocompatibility leukocyte antigen (HLA)-Cw4, a ligand for the KIR2D natural killer cell inhibitory receptor.
  J Exp Med, 190, 113-123.
PDB code: 1qqd
10359113 R.Khanna, S.L.Silins, Z.Weng, D.Gatchell, S.R.Burrows, and L.Cooper (1999).
Cytotoxic T cell recognition of allelic variants of HLA B35 bound to an Epstein-Barr virus epitope: influence of peptide conformation and TCR-peptide interaction.
  Eur J Immunol, 29, 1587-1597.  
10322158 S.Buus (1999).
Description and prediction of peptide-MHC binding: the 'human MHC project'.
  Curr Opin Immunol, 11, 209-213.  
  10422827 S.Krebs, D.Rognan, and J.A.López de Castro (1999).
Long-range effects in protein--ligand interactions mediate peptide specificity in the human major histocompatibilty antigen HLA-B27 (B*2701).
  Protein Sci, 8, 1393-1399.  
9722926 A.Sette, and J.Sidney (1998).
HLA supertypes and supermotifs: a functional perspective on HLA polymorphism.
  Curr Opin Immunol, 10, 478-482.  
9700508 E.J.Collins, and J.A.Frelinger (1998).
Altered peptide ligand design: altering immune responses to class I MHC/peptide complexes.
  Immunol Rev, 163, 151-160.  
9619483 I.B.Jakobsen, X.Gao, S.Easteal, and G.Chelvanayagam (1998).
Correlating sequence variation with HLA-A allelic families: implications for T cell receptor binding specificities.
  Immunol Cell Biol, 76, 135-142.  
9864030 J.Yagüe, J.Vázquez, and J.A.López de Castro (1998).
A single amino acid change makes the peptide specificity of B*3910 unrelated to B*3901 and closer to a group of HLA-B proteins including the malaria-protecting allotype HLA-B53.
  Tissue Antigens, 52, 416-421.  
9741848 M.Bouvier, H.C.Guo, K.J.Smith, and D.C.Wiley (1998).
Crystal structures of HLA-A*0201 complexed with antigenic peptides with either the amino- or carboxyl-terminal group substituted by a methyl group.
  Proteins, 33, 97.
PDB code: 1b0r
9643627 P.J.Fairchild (1998).
Presentation of antigenic peptides by products of the major histocompatibility complex.
  J Pept Sci, 4, 182-194.  
9528009 V.Apostolopoulos, S.A.Lofthouse, V.Popovski, G.Chelvanayagam, M.S.Sandrin, and I.F.McKenzie (1998).
Peptide mimics of a tumor antigen induce functional cytotoxic T cells.
  Nat Biotechnol, 16, 276-280.  
9586631 Y.H.Ding, K.J.Smith, D.N.Garboczi, U.Utz, W.E.Biddison, and D.C.Wiley (1998).
Two human T cell receptors bind in a similar diagonal mode to the HLA-A2/Tax peptide complex using different TCR amino acids.
  Immunity, 8, 403-411.
PDB code: 1bd2
9039778 E.Y.Jones (1997).
MHC class I and class II structures.
  Curr Opin Immunol, 9, 75-79.  
9192660 G.K.Balendiran, J.C.Solheim, A.C.Young, T.H.Hansen, S.G.Nathenson, and J.C.Sacchettini (1997).
The three-dimensional structure of an H-2Ld-peptide complex explains the unique interaction of Ld with beta-2 microglobulin and peptide.
  Proc Natl Acad Sci U S A, 94, 6880-6885.
PDB code: 1ld9
9032063 J.W.Schwabe (1997).
The role of water in protein-DNA interactions.
  Curr Opin Struct Biol, 7, 126-134.  
9379075 K.D.Smith, Z.B.Kurago, and C.T.Lutz (1997).
Conformational changes in MHC class I molecules. Antibody, T-cell receptor, and NK cell recognition in an HLA-B7 model system.
  Immunol Res, 16, 243-259.  
9316393 M.A.Batalia, and E.J.Collins (1997).
Peptide binding by class I and class II MHC molecules.
  Biopolymers, 43, 281-302.  
9114037 O.Mandelboim, S.B.Wilson, M.Valés-Gómez, H.T.Reyburn, and J.L.Strominger (1997).
Self and viral peptides can initiate lysis by autologous natural killer cells.
  Proc Natl Acad Sci U S A, 94, 4604-4609.  
9039787 P.Cresswell, and J.C.Howard (1997).
Antigen recognition.
  Curr Opin Immunol, 9, 71-74.  
9209505 P.J.Goulder, S.W.Reid, D.A.Price, C.A.O'Callaghan, A.J.McMichael, R.E.Phillips, and E.Y.Jones (1997).
Combined structural and immunological refinement of HIV-1 HLA-B8-restricted cytotoxic T lymphocyte epitopes.
  Eur J Immunol, 27, 1515-1521.  
9174154 S.Szmania, K.Seurynck, and L.A.Baxter-Lowe (1997).
Nucleotide sequence of HLA-B*5505, which expresses a unique HLA class I polymorphism.
  Tissue Antigens, 49, 537-539.  
9174606 V.Braud, E.Y.Jones, and A.McMichael (1997).
The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9.
  Eur J Immunol, 27, 1164-1169.  
9219685 Z.Zeng, A.R.Castaño, B.W.Segelke, E.A.Stura, P.A.Peterson, and I.A.Wilson (1997).
Crystal structure of mouse CD1: An MHC-like fold with a large hydrophobic binding groove.
  Science, 277, 339-345.
PDB code: 1cd1
9034863 J.A.Frelinger, and M.McMillan (1996).
The role of peptide specificity in MHC class I-restricted allogeneic responses.
  Immunol Rev, 154, 45-58.  
8624811 K.J.Smith, S.W.Reid, D.I.Stuart, A.J.McMichael, E.Y.Jones, and J.I.Bell (1996).
An altered position of the alpha 2 helix of MHC class I is revealed by the crystal structure of HLA-B*3501.
  Immunity, 4, 203-213.
PDB code: 1a1n
9034864 S.Joyce, and S.G.Nathenson (1996).
Alloreactivity, antigen recognition and T-cell selection: three diverse T-cell recognition problems with a common solution.
  Immunol Rev, 154, 59.  
8976183 S.W.Reid, S.McAdam, K.J.Smith, P.Klenerman, C.A.O'Callaghan, K.Harlos, B.K.Jakobsen, A.J.McMichael, J.I.Bell, D.I.Stuart, and E.Y.Jones (1996).
Antagonist HIV-1 Gag peptides induce structural changes in HLA B8.
  J Exp Med, 184, 2279-2286.
PDB codes: 1agb 1agc 1agd 1age 1agf
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB codes are shown on the right.